Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19 2020-11-16 05:00
Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center 2020-11-14 12:40
China Biologic Products to Report Third Quarter 2020 Financial Results 2020-11-13 21:00
I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020 2020-11-11 21:00
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting 2020-11-10 22:30
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting 2020-11-09 21:12
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update 2020-11-09 21:00
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit 2020-11-09 20:30
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R) 2020-11-09 18:22
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim 2020-11-09 18:07
PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period 2020-11-05 21:00
Gracell Biotechnologies Announces Two Oral Presentations at the ASH Annual Meeting and Exposition 2020 2020-11-05 11:52
Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation 2020-11-04 20:00
Great Bay Bio Announces Its First AI-enabled Bioprocessing Platform-Klone 4.0, Reducing Cell Line Development Time and Cost by Up to 80% 2020-11-02 22:00
Senhwa Announces Multiple IND application submissions to U.S. FDA for Silmitasertib as a Potential Treatment for COVID-19 2020-11-02 22:00
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates 2020-11-02 19:00
Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development 2020-11-02 08:27
TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000 2020-11-02 07:30
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide 2020-10-29 20:00
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center 2020-10-29 08:38